SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SeQuent Scientific reports consolidated net profit of Rs 10.50 crore in Q4

23 May 2017 Evaluate

SeQuent Scientific has reported results for fourth quarter and year ended March 31, 2017.     

The company has reported a net profit of Rs 3.23 crore for the quarter ended March 31, 2017 as compared to net loss of Rs 0.32 crore for the same quarter in the previous year. Total income from operations of the company increased by 9.63% at Rs 109.61 crore for quarter under review as compared to Rs 99.98 crore for the quarter ended March 31, 2016.  

On consolidated basis, the company has reported a net profit of Rs 10.50 crore for the quarter ended March 31, 2017 as compared to net loss of Rs 14.57 crore for the same quarter in the previous year. Total income of the company increased by 60.15% at Rs 254.49 crore for quarter under review as compared to Rs 158.91 crore for the same quarter ended previous year. 

For the year ended March 31, 2017, the company posted a net loss of Rs 0.01 crore as compared to net profit of Rs 10.39 crore in FY16. Total income of company decreased by 2.81% at Rs 412.31 crore for year under review as compared to Rs 424.22 crore for the year ended March 31, 2016.

For the year ended March 31, 2017, on the consolidated basis, the company has posted a net loss of Rs 16.39 crore as compared to a net loss of Rs 16.38 crore in the previous year. However, total income of the company increased by 45.92% at Rs 926.16 crore for year under review as compared to Rs 634.70 crore for the year ended March 31, 2016.

Viyash Scientific Share Price

208.90 0.05 (0.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×